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Background: We performed perfusion CT (P-CT) and angiography of the 
pancreas in patients with severe acute pancreatitis (SAP) and compared the 
usefulness of these two methods in predicting the development of pancreatic 
necrosis.  
Methods: We compared P-CT and angiography results taken within three days 
after symptoms onset in 21 SAP patients. We divided the pancreas into three 
areas, the head, body and tail, and examined each area for perfusion defects 
(via P-CT) and the arterial vasospasms (by angiography). Three weeks later, all 
patients underwent contrast-enhanced CT to confirm the development of 
pancreatic necrosis.  
Results: Of the 21 SAP patients, 16 exhibited perfusion defects, while 17 proved 
positive for vasospasms in at least one area. Fourteen patients developed 
pancreatic necrosis. Of the 63 pancreatic areas from 21 SAP patients, perfusion 
defects appeared in 25 areas (39.7%), 24 of which showed vasospasms (96.0%). 
Angiography showed 33 areas with vasospasms (52.4%), of which 24 showed 
perfusion defects (72.7%). Of the 25 areas with perfusion defects, 21 developed 
pancreatic necrosis (84.0%). Of the 33 areas with vasospasms, 21 developed 
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necrosis (63.6%). Pancreatic necrosis developed only in the areas positive both 
for perfusion defects and for vasospasms. No areas without perfusion defect or 
vasospasms developed pancreatic necrosis. P-CT predicted the development of 
pancreatic necrosis with significantly higher accuracy than angiography.  
Conclusion: While both P-CT and angiography are useful in predicting the 
development of pancreatic necrosis, P-CT appears to be superior in it prediction 
in patients with SAP. 




  Despite recent improvements in the treatment of severe acute pancreatitis 
(SAP), mortality rates remain high1, reaching as high as 20% in Japan.2 SAP 
often leads to necrotizing pancreatitis,2 the most severe form of pancreatitis, that 
results from pancreatic ischemia caused by vasospasms of the intra-pancreatic 
arteries.3 Accordingly, early detection of vasospasms in the intra-pancreatic 
arteries is critical in successfully treating SAP and improving prognosis.4, 5 At 
present, vasospasms of the intra-pancreatic arteries can only be diagnosed 
accurately by angiography. However, neither unstable nor emergent cases lend 
themselves to examination by angiography: thus, an alternative non-invasive 
method for diagnosing pancreatic ischemia is required. 
  We recently reported that perfusion CT is capable of detecting pancreatic 
perfusion defects non-invasively, and accurately predict the development of 
pancreatic necrosis at the early stages of SAP.6, 7 Since vasospasms of the 
intra-pancreatic arteries are likely to cause perfusion defects in the pancreas, it 
might appear reasonable to assume that perfusion defects detected by perfusion 
CT reflect vasospasms of the intra-pancreatic arteries. However, no reports to 
date have examined the relationship between pancreatic perfusion defects 
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detected by perfusion CT6, 8-11 and vasospasms of the intra-pancreatic arteries 
as diagnosed by angiography.3-5 
  In this study, we examined the relationship between the results of pancreatic 
perfusion defects detected by perfusion CT and those of vasospasms of the 
intra-pancreatic arteries diagnosed by angiography in patients with SAP. We 
then compared the usefulness of the two methods in predicting the development 





The study population consisted of 21 consecutive adult patients with SAP  
admitted to the department of gastroenterology at Kurashiki Central Hospital, 
Kurasiki, or Kyoto University Hospital, Kyoto, Japan, within three days of the 
onset of symptoms during the period from 2003 through 2008. A diagnosis of 
acute pancreatitis was based on physical findings of acute abdominal pain, 
laboratory findings of abnormal elevated serum amylase and serum lipase levels 
(more than three times above normal), and radiographic (CT) findings of 
pancreatitis12, 13 (Figures 1A and 2A). SAP was diagnosed by Atlanta 
classification. 14, 15 After patients were diagnosed with SAP in the emergency 
room, perfusion CT was performed. Angiography was performed following 
perfusion CT. The study excluded patients in whom acute pancreatitis was 
related to cancer or a side effect of endoscopic retrograde 
cholangiopancreatography.  
 All patients were treated with fluid resuscitation in the intensive care unit to 
maintain central venous pressures above 8 mmHg. The patients were also 
administered a continuous regional arterial infusion therapy of prophylactic 
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antibiotics (TIENAM®; Imipenem/cilastatin, BANYU PHARMACEUTICAL CO., 
LTD, Tokyo, Japan) with anticoagulation factors (FUTHAN®; nafamostat 
mesilate, TORII PHARMACEUTICAL CO., LTD, Tokyo, Japan) for 5 days. 
16-18 To perform regional arterial infusion therapy, the tips of the catheters were 
placed at both celiac trunk and superior mesenteric artery. Patients who were 
free of severe ileus were administered enteral feedings through a nasojejunal 
tube.19  
 
Study protocol  
We evaluated sequentially-performed perfusion CT and angiographies of 21 
patients with SAP, dividing the pancreas into three areas (the head, body, and 
tail) and examining each area for perfusion defects by perfusion CT and arterial 
vasospasms by angiography (Figures 1 and 2). The development of pancreatic 
necrosis was confirmed by conventional contrast-enhanced CT (CECT) at three 
weeks following onset. The study protocol was approved by the Ethics 
Committee of each institution. 
 
Perfusion CT protocol 
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A 16-slice or 64-slice helical CT scanner (Toshiba Aquillion 16® or Toshiba 
Aquillion 64®, Toshiba Medical Systems Co., Ltd., Tochigi, Japan) was used. 
After obtaining transaxial images of the upper abdomen, we selected four 
sections (slice thickness of 5.0 mm), covering as much of the pancreas as 
possible. As previously described,7 perfusion CT was performed after a bolus 
injection of 600 mgI/kg of contrast matter (Iomeron®; iomeprol, Eisai Co., Ltd., 
Tokyo, Japan ) of 10 seconds duration into a cubital vein [ 80 kVp, 40 mA, 1.5 
s/rot, 60 sec, radiological exposure; 63.8±4.7 mGy (CT dose index) ].20  
 For each pixel, changes in CT value were observed and a time-density 
curve obtained.6, 7,21 Commercially-available software (box-MTF, Ziosoft, Inc., 
Tokyo, Japan) was then used to analyze the time-density curve. We calculated 
the pancreatic blood flow at each pixel by perfusion CT, as previously 
described.6, 7,22, 23 The deconvolution method was adjusted to enable analysis of 
pancreatic blood flow,  which was then displayed as color maps.6, 7,24-26 The 
deconvolution method required placement of regions of interest on one artery 
and one vein to generate arterial input functions and venous outflow functions, 
respectively.24, 27-29 In this study, the splenic artery was regarded as input and 
the splenic vein as outflow.6, 7, 30 
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In perfusion CT, the color scale appears as a bar on the left edge of the 
perfusion images (Figures 1B and 2B). The red areas in the perfusion images 
indicate faster blood flow (>150 ml/100 g/min), while purple areas indicate 
slower blood flow (<5 ml/100 g/min).6, 7 
 
Diagnosis of pancreatic perfusion defect by perfusion CT 
We made a diagnosis of pancreatic perfusion defect by perfusion CT as 
previously described.6, 7 In brief, if the color map on perfusion CT demonstrated 
homogeneously high pancreatic blood flow within the entire pancreatic area, the 
area was determined to be negative for pancreatic perfusion defects (Figure 1B). 
If the color map on perfusion CT demonstrated partial pancreatic perfusion 
defect with pancreatic blood flow slower than hepatic blood flow (Figure 2B, red 
arrow), the area was defined to be positive for a pancreatic perfusion defect.  
 
Diagnosing vasospasms of the intra-pancreatic arteries  
We applied angiography to examine the celiac artery, supra mesenteric 
artery, and branches for arterial vasospasms.3, 4 Vasospasms of the arteries 
were defined as luminal narrowing of <50% (Figure 2C). 
 
Diagnosing pancreatic necrosis 
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The final diagnosis of pancreatic necrosis was made by performing 




The unadjusted relationship between areas with perfusion defects and areas 
with vasospastic arteries was assessed by chi-square analysis. The unadjusted 
relationship between the results of prediction for development of pancreatic 
necrosis by perfusion CT and by angiography was also assessed by chi-square 
analysis. P values below 0.05 were regarded as statistically significant. All 





Twenty-one SAP patients underwent both perfusion CT and angiography in 
a sequential manner within three days following the onset of symptoms. The 
average age and APACHE II score of the SAP patients were 53.2±13.2 and 
12.0±6.8 (mean ± standard deviation), respectively (Table 1). Of the 21 patients, 
14 patients developed pancreatic necrosis, as diagnosed by conventional CECT 
performed three weeks following onset. Four of these SAP patients died (Table 
1). Causes of death included infectious endocarditis, multiple organ failure due 
to infected pancreatic necrosis, multiple organ failure with systemic infection, 
and non-occlusive mesenteric ischemia (Table 1).  
Of the 21 SAP patients, 16 were diagnosed as positive for pancreatic 
perfusion defects by perfusion CT in at least one area, while five were diagnosed 
as negative in all areas. On the other hand, of the 21 patients, 17 were 
diagnosed as positive in at least one area for vasospasms of the intra-pancreatic 
arteries by angiography, while four were negative in all areas (Table 1). 
  Of the 63 pancreatic areas (head, body, and tail) analyzed in the 21 SAP 
patients, seven occurred in the head areas, 12 in the body areas, and six in the 
tail areas, for a total of 25 areas (39.7%) with perfusion defects. Eight head 
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areas, 16 body areas, and nine tail areas for a total of 33 areas (52.4%) were 
diagnosed with vasospastic arteries by angiography (Table 1).  
  Of the 25 areas with perfusion defects detected by perfusion CT, 24 areas 
were positive for vasospastic arteries (96.0%) and only one negative. Of the 
remaining 38 areas without perfusion defects, nine areas were positive and 29 
areas negative for vasospastic arteries (Table 2). Of the 33 areas with 
vasospastic arteries, 24 were positive (72.7%) and nine negative for perfusion 
defects by perfusion CT. Of the remaining 30 areas without vasospastic arteries, 
only one area was positive for perfusion defects. Thus, a diagnosis of the 
presence or absence of perfusion defects by perfusion CT and the presence or 
absence of vasospastic arteries by angiography was concordant for 53 (84.1%) 
of the 63 areas (Table 2). 
  Of the 25 areas with perfusion defects as determined by perfusion CT, 21 
finally developed pancreatic necrosis (84.0%). Of the 33 areas with vasospastic 
arteries as determined by angiography, 21 developed pancreatic necrosis 
(63.6%). Notably, pancreatic necrosis developed only in areas positive for both 
perfusion defects and vasospasms of the intra-pancreatic arteries. None of the 
areas free of either perfusion defects or vasospasms developed pancreatic 
14 
 
necrosis (Table 2). Thus, both perfusion CT and angiography successfully 
predicted the development of pancreatic necrosis at statistically significant levels 
(P < 0.01 and P < 0.05, respectively) (Tables 2 and 3).  
  While perfusion CT and angiography showed the same sensitivity (100% vs. 
100%) and negative predictive values (NPV; 100% vs. 100%) in predicting the 
development of pancreatic necrosis, perfusion CT showed higher specificity 
(90.4% vs. 71.4%) and a higher positive predictive value (PPV; 84.0% vs. 
63.6%), with a positive finding under perfusion CT associated with a higher 
likelihood for developing pancreatic necrosis than areas identified by 
angiography (10.5 vs. 3.5) (Table 3). The accuracy of perfusion CT in predicting 
the development of pancreatic necrosis was significantly greater than for 




Pancreatic necrosis is a serious complication of SAP that determines patient 
prognosis.31, 32 To improve the prognosis for SAP, it is crucial to predict the 
development of necrosis early and to initiate treatment as early as possible. 
Pancreatic necrosis results from pancreatic ischemia caused by vasospasms of 
the intra-pancreatic arteries.3-5 While angiography is currently the only 
established method for detecting vasospasms of the intra-pancreatic arteries,3, 4 
angiography is often difficult to perform in cases of unstable or emergent patients. 
In response to these drawbacks, we recently applied perfusion CT for patients 
with SAP. We found perfusion CT useful in the early detection of ischemic 
change in the pancreas. Here, we compared usefulness of angiography and 
perfusion CT in predicting the development of pancreatic necrosis in 21 patients 
with SAP, and found that both perfusion CT and angiography are useful for 
predicting development of pancreatic necrosis, but perfusion CT is superior to 
angiography for prediction. 
Our study divided the whole pancreas into three areas, the head, body, and 
tail, and evaluated the results of perfusion CT and angiography for each area. 
Our examination showed 24 areas positive for both perfusion defects by 
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perfusion CT and vasospasms by angiography and 29 areas negative by either 
method. Thus, the results of perfusion CT and angiography were concordant in 
84.1% of all pancreatic areas from the 21 patients. The data indicates a high 
correlation between perfusion defects detected by perfusion CT and 
vasospasms of the intra-pancreatic arteries detected by angiography. However, 
it is worth noting that areas with vasospastic arteries clearly outnumber areas 
with perfusion defects (33 vs. 25); Moreover, although not all areas positive for 
vasospastic arteries of the intra-pancreatic arteries by angiography were positive 
for perfusion defects, most areas with perfusion defects by perfusion CT were 
positive for vasospasms of the intra-pancreatic arteries, potentially suggesting 
that perfusion defects detected by perfusion CT in most cases result from 
vasospasms of the intra-pancreatic arteries. In a finding that supports this idea, 
Inoue et al. reported that endothelin-1, which can produce spastic change in the 
arteries, is an important mediator in the development of pancreatic ischemia in 
cases of severe acute pancreatitis.33  
  Our study found both perfusion CT and angiography useful in predicting the 
development of pancreatic necrosis. Indeed, sensitivity and NPV were 100% for 
both methods, and specificities were 90.4% and 71.4%, respectively, for 
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perfusion CT and angiography. The angiography data in this study was 
comparable to data from previous studies,3,4 while the perfusion CT data was 
comparable to data from our previous study.7 An important finding of the present 
study is that 84.0% of the areas with perfusion defects developed pancreatic 
necrosis; this was true of only 63.6% of the areas with vasospastic arteries. 
Moreover, none of the areas negative for both perfusion defects or vasospastic 
arteries developed pancreatic necrosis. In short, perfusion CT proved more 
accurate in predicting the development of pancreatic necrosis than angiography. 
The reasons why the discrepancy exists between angiography and perfusion 
CT and why perfusion CT is superior to angiography for predicting pancreatic 
necrosis in patients with SAP are unknown at present.  It has been shown that 
perfusion CT can diagnose microcirculation failure24,29,34,35.  In contrast, 
angiography can diagnose spastic lesions of large arteries, which might not 
always result in impairment of microcirculation. Thus, our data might suggest 
that vasospasm of large arteries does not always result in impairment of 
microcirculation. In any event, our present data may suggest that disturbance of 
microcirculation detected by perfusion CT is a critical event for development of 
pancreatic necrosis, and thus, perfusion CT is superior to angiography for 
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predicting development of pancreatic necrosis. 
We should emphasize that pancreatic necrosis developed only in areas 
positive for both perfusion CT and angiography, and none of the areas negative 
by either method developed necrosis in this study. Therefore, patients positive 
under both perfusion CT and angiography would appear to be at very high risk 
for pancreatic necrosis. In contrast, a negative result for either perfusion CT or 
angiography alone might rule out the future development of necrosis. This data 
is consistent with our previous study,7 which showed that 9 of 10 patients in 
whom perfusion defects were detected by perfusion CT developed pancreatic 
necrosis, whereas necrosis did not develop in any patient in whom no perfusion 
defects were detected. The data is also in agreement with the report by Takeda 
et al. showing that by analyzing 147 patients with acute necrotizing pancreatitis 
no pancreatic tissue with the absence of vasospasms in the intra-pancreatic 
arteries developed pancreatic necrosis.3  
As previously reported, prognosis of acute necrotizing pancreatitis1-3 and that 
of ischemic acute pancreatitis4-9 are generally poor.  However, the prognosis of 
our SAP patients with vasospasm or ischemia was not so poor in this study. 
Although the reason for such different outcomes between our patients and those 
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in previous reports is not clear at present, it may be emphasized that all of our 
cases were treated with regional arterial infusion therapy in early stage of SAP. 
Thus, it is possible that the prognosis of the SAP patients was influenced and 
improved by regional arterial infusion therapy in our study16-18, although whether 
or not regional arterial infusion therapy really improves prognosis of SAP 
patients with pancreatic ischemia should be elucidated in future studies. It may 
be noted that some cases who showed pancreatic ischemia by perfusion CT or 
vasospasm by angiography did not develop pancreatic necrosis (case 4, 5, 15 
and 18-21) in this study.  Although the reason for such discrepancy is not clear 
at present, again it may be possible that regional arterial infusion therapy may 
have prevented development of pancreatic necrosis in our study16-18.  
There has been vigorous recent debate on treatment methods for SAP. For 
instance, the effectiveness of prophylactic antibiotics36-41 in cases of SAP 
remains an open question. Some reports argue for the efficacy of prophylactic 
antibiotics,41 while others reach the opposite finding.39,40  If the goal of a study is 
to determine whether administering prophylactic antibiotics prevents pancreatic 
necrosis, the most severe manifestation of SAP, antibiotics must, of course, be 
administered before pancreatic necrosis actually develops. Indeed, Besselink et 
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al. reported that in their cohort study infection occurred early in acute 
pancreatitis and had a significant impact on mortality, suggesting that  
prophylactic strategies should be examined as early intervention.41 In this regard, 
all previous studies have involved the administration of antibiotics to patients in 
whom pancreatic necrosis had already been diagnosed.39-41 As we demonstrate 
in this paper, perfusion CT offers a safe and accurate route to diagnosing 
pancreatic ischemia, a precondition of pancreatic necrosis. Thus, by enabling 
the diagnosis of pancreatic ischemia, perfusion CT should prove useful in 
studies investigating effectiveness of the administration of antibiotics as a 
prophylactic measure. 
  In conclusion, this study found both perfusion CT and angiography useful in 
predicting the development of pancreatic necrosis, although perfusion CT 
proved more accurate. Perfusion CT, moreover, is less invasive and more readily 
available than angiography. Further study is needed to ascertain whether 
perfusion CT can substitute for angiography as a primary screening method 
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Figure 1 Severe acute pancreatitis without vasospasms of the 
intra-pancreatic arteries or pancreatic perfusion defects 
Shown here are images from patient 2 in Table 2. The pancreas is 
homogeneously enhanced in contrast-enhanced CT (A). In perfusion CT (B), 
pancreatic blood flow is homogeneously high, and the pancreas is free of any 
areas with perfusion defects (red arrow). Angiography showed no vasospastic 
arteries in the pancreas. Mild diffuse staining of the pancreas was observed 
(White arrows) (C). Contrast-enhanced CT three weeks later showed no signs of 
pancreatic necrosis (D). 
 
Figure 2 Severe acute pancreatitis with vasospasms of the 
intra-pancreatic arteries and pancreatic perfusion defects 
Shown here are images from patient 6 in Table 2. The pancreas is 
homogeneously enhanced in contrast-enhanced CT (A). Perfusion CT shows 
markedly slower blood flow (red arrows) in the pancreas body (B). Thus, this 
case was diagnosed as positive for perfusion defect. Angiography (C) shows the 
splenic artery (white arrow) and its branches (Blue arrows) were found to be 
positive for vasospasms in the pancreas head, body and tail. Contrast-enhanced 
CT three weeks later detected pancreatic necrosis in the body (D, yellow arrow), 
and viable tissue in the tail (the image was not included in this slice).  
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